Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Early Safety and Feasibility Results from a Phase II Trial of De-Escalated Ptcy and Ruxolitinib for Gvhd Prophylaxis in Older Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Sameem Abedin, Fateeha Furqan, Lyndsey Runaas, Walter Longo, Nirav N. Shah, Timothy S. Fenske, Marcelo C. Pasquini, William R Drobyski, Xue-Zhong Yu, Mehdi Hamadani

Blood (2024) 144 (Supplement 1): 1039.

https://doi.org/10.1182/blood-2024-200832

Published: 2024

Journal Articles

ER Stress Sensor PERK Boosts T Cell Pathogenicity in Gvhd through Regulating ERAD

Qiao Cheng, Heejin Choi, Yongxia Wu, Linlu Tian, Michael Hendrix, Xue-Zhong Yu

Blood (2024) 144 (Supplement 1): 4780.

https://doi.org/10.1182/blood-2024-206278

Published: 2024

Journal Articles

Retinoic Acid Regulates Donor Myeloid Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation in Mice

Xinlei Li, Jianwei Zheng, Dian Zhou, Rachel Limpert, Brian Taylor, Linlu Tian, Xue-Zhong Yu, William R. Drobyski, Xiao Chen

Blood (2022) 140 (Supplement 1): 4482.

https://doi.org/10.1182/blood-2022-162723

Published: 2022

Journal Articles

ER Stress Sensor PERK Regulates T-Cell Allogeneic and Anti-Tumor Responses Distinctly

Hee-Jin Choi, Yongxia Wu, Linlu Tian, Kaipo Yang, Xue-Zhong Yu

Blood (2022) 140 (Supplement 1): 4475–4476.

https://doi.org/10.1182/blood-2022-169555

Published: 2022

Journal Articles

S1P/S1PR1 Signaling Differentially Regulates Allogeneic Response of CD4 and CD8 T Cells through Modulating Mitochondrial Content and Metabolism

Linlu Tian, Yongxia Wu, Hee-Jin Choi, Xinlei Li, Xiao Chen, Xue-Zhong Yu

Blood (2022) 140 (Supplement 1): 4491–4492.

https://doi.org/10.1182/blood-2022-170078

Published: 2022

Journal Articles

Transcription Factor Fli-1 Regulates T Cell Immunity and Tolerance in Gvh and GVL Responses

Yongxia Wu, Steven Schutt, Arjun Kharel, Hee-Jin Choi, Weiguo Cui, Xian Zhang, Yaacov Ben-David, Xue-Zhong Yu

Blood (2022) 140 (Supplement 1): 7350–7351.

https://doi.org/10.1182/blood-2022-170592

Published: 2022

Journal Articles

Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity

Jianming Wang, Chun-Yuan Chang, Xue Yang, Fan Zhou, Juan Liu, Sining Zhu, Xue-Zhong Yu, Chen Liu, Timothy E. O’Sullivan, Ping Xie, Zhaohui Feng, Wenwei Hu

Blood (2022) 140 (19): 2076–2090.

https://doi.org/10.1182/blood.2022015677

Published: 2022

Includes: Supplemental data

Journal Articles

Targeting Pim2 for Improving T-Cell Effector Function and Promoting Cancer Immunotherapy

Yongxia Wu, Linlu Tian, Corey Mealer, Hee-Jin Choi, Xue-Zhong Yu

Blood (2021) 138 (Supplement 1): 1720.

https://doi.org/10.1182/blood-2021-154410

Published: 2021

Journal Articles

Ridd Is Required for the Prevention of Chronic Gvhd By Targeting IRE-1a/Xbp-1s Signaling

Hee-Jin Choi, Chih-Hang Anthony Tang, Linlu Tian, Yongxia Wu, Mohammed Hanief Sofi, Steven Douglas Schutt, Chih-Chi Andrew Hu, Xue-Zhong Yu

Blood (2021) 138 (Supplement 1): 1681.

https://doi.org/10.1182/blood-2021-153339

Published: 2021

Journal Articles

S1P/S1PR1 Signalis Required for Optimal T-Cell Pathogenicity to Induce Gvhd By RegulatingDrp1/mTOR Axis

Linlu Tian, Yongxia Wu, Hee-Jin Choi, Xiaohui Sui, Mohammed Hanief Sofi, Mohamed Faisal Kassir, Paul J Martin, Shikhar Mehrotra, Besim Ogretmen, Xue-Zhong Yu

Blood (2021) 138 (Supplement 1): 643.

https://doi.org/10.1182/blood-2021-149660

Published: 2021

Journal Articles

Sting Negatively Regulates Allogeneic T-Cell Responses By Constraining Antigen-Presenting Cell Function

Yongxia Wu, PhD MD, Chih-Hang Anthony Tang, Corey Mealer, David Bastian, PhD, Mohammed Hanief Sofi, PhD MS, Linlu Tian, PhD, Steven Douglas Schutt, PhD, Hee-Jin Choi, PhD, Taylor Ticer, Mengmeng Zhang, MD, Lei Huang, Andrew L. Mellor, Chih-Chi Andrew Hu, Xue-Zhong Yu, MD MS

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-139860

Published: 2020

Journal Articles

Cereblon harnesses Myc-dependent bioenergetics and activity of CD8 + T lymphocytes

Blood (2020) 136 (7): 857–870.

https://doi.org/10.1182/blood.2019003257

Published: 2020

Includes: Supplemental data

Journal Articles

Microrna-31 Regulates T-Cell Metabolism Via HIF1α and Promotes Effector Function

Yongxia Wu, PhD MD, Mengmeng Zhang, MD, David Bastian, Mohammed Hanief Sofi, PhD MS, Steven Douglas Schutt, BS, Hee-Jin Choi, PhD, Corey Mealer, Hung D Nguyen, PhD, Linlu Tian, Xue-Zhong Yu, MD MS

Blood (2019) 134 (Supplement_1): 623.

https://doi.org/10.1182/blood-2019-131587

Published: 2019

Journal Articles

Fli-1 Regulates Multiple T-Cell Subsets during Inflammatory Responses and Experimental Graft-Versus-Host Disease

Steven Douglas Schutt, BS, David Bastian, Hee-Jin Choi, PhD, Yongxia Wu, PhD MD, Mohammed Hanief Sofi, PhD MS, Hung Nguyen, PhD, Xian Zhang, PhD, Xue-Zhong Yu, MD MS

Blood (2019) 134 (Supplement_1): 3201.

https://doi.org/10.1182/blood-2019-127577

Published: 2019

Journal Articles

Potential Role of IL-39 in the Development of Gvhd

David Bastian, Hung Nguyen, PhD, Yongxia Wu, PhD MD, Steven Douglas Schutt, BS, Mohammed Hanief Sofi, PhD MS, Yuejun Liu, PhD, Eric Bartee, PhD, Xue-Zhong Yu, MD MS

Blood (2019) 134 (Supplement_1): 3206.

https://doi.org/10.1182/blood-2019-131251

Published: 2019

Journal Articles

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice

Anusara Daenthanasanmak, Supinya Iamsawat, Paramita Chakraborty, Hung D. Nguyen, David Bastian, Chen Liu, Shikhar Mehrotra, Xue-Zhong Yu

Blood (2019) 133 (3): 266–279.

https://doi.org/10.1182/blood-2018-07-863233

Published: 2019

Includes: Supplemental data

Journal Articles

Vitamin C Stabilizes CD8iTregs and Enhances Their Therapeutic Potential in Controlling GvHD and Leukemia Relapse

Supinya Iamsawat, Anusara Daenthanasanmak, PhD, Xue-Zhong Yu, MD MS

Blood (2018) 132 (Supplement 1): 4532.

https://doi.org/10.1182/blood-2018-99-117036

Published: 2018

Journal Articles

Association of Donor T Cell Repertoire in Host Lymphoid and Target Organs and Gvhd Development

Yongxia Wu, PhD MD, Jianing Fu, PhD, Anusara Daenthanasanmak, PhD, Hung D Nguyen, PhD, Mohammed Hanief Sofi, PhD MS, Jessica Lauren Heinrichs, BS, MS, Yuejun Liu, PhD, Steven Douglas Schutt, BS, David Bastian, Xue-Zhong Yu, MD MS

Blood (2018) 132 (Supplement 1): 4525.

https://doi.org/10.1182/blood-2018-99-119956

Published: 2018

Journal Articles

MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice

Yongxia Wu, Steven Schutt, Katelyn Paz, Mengmeng Zhang, Ryan P. Flynn, David Bastian, M. Hanief Sofi, Hung Nguyen, Min Dai, Chen Liu, Ying-Jun Chang, Bruce R. Blazar, Xue-Zhong Yu

Blood (2018) 131 (17): 1974–1986.

https://doi.org/10.1182/blood-2017-06-789321

Published: 2018

Includes: Supplemental data

Journal Articles

U Distinct Roles of IL-12Rβ1 and IL-23R in the Development of Acute and Chronic Gvhd

David Bastian, Hung D Nguyen, PhD, Yongxia Wu, PhD MD, Steven Douglas Schutt, BS, Anusara Daenthanasanmak, Mohammed Hanief Sofi, PhD MS, Supinya Iamsuwat, Mengmeng Zhang, MD, Xue-Zhong Yu, MD MS

Blood (2017) 130 (Supplement 1): 1005.

https://doi.org/10.1182/blood.V130.Suppl_1.1005.1005

Published: 2017

NARROW

Early Safety and Feasibility Results from a Phase II Trial of De-Escalated Ptcy and Ruxolitinib for Gvhd Prophylaxis in Older Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

ER Stress Sensor PERK Boosts T Cell Pathogenicity in Gvhd through Regulating ERAD

Retinoic Acid Regulates Donor Myeloid Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation in Mice

ER Stress Sensor PERK Regulates T-Cell Allogeneic and Anti-Tumor Responses Distinctly

S1P/S1PR1 Signaling Differentially Regulates Allogeneic Response of CD4 and CD8 T Cells through Modulating Mitochondrial Content and Metabolism

Transcription Factor Fli-1 Regulates T Cell Immunity and Tolerance in Gvh and GVL Responses

Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity

Targeting Pim2 for Improving T-Cell Effector Function and Promoting Cancer Immunotherapy

Ridd Is Required for the Prevention of Chronic Gvhd By Targeting IRE-1a/Xbp-1s Signaling

S1P/S1PR1 Signalis Required for Optimal T-Cell Pathogenicity to Induce Gvhd By RegulatingDrp1/mTOR Axis

Sting Negatively Regulates Allogeneic T-Cell Responses By Constraining Antigen-Presenting Cell Function

Cereblon harnesses Myc-dependent bioenergetics and activity of CD8 + T lymphocytes

Microrna-31 Regulates T-Cell Metabolism Via HIF1α and Promotes Effector Function

Fli-1 Regulates Multiple T-Cell Subsets during Inflammatory Responses and Experimental Graft-Versus-Host Disease

Potential Role of IL-39 in the Development of Gvhd

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice

Vitamin C Stabilizes CD8iTregs and Enhances Their Therapeutic Potential in Controlling GvHD and Leukemia Relapse

Association of Donor T Cell Repertoire in Host Lymphoid and Target Organs and Gvhd Development

MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice

U Distinct Roles of IL-12Rβ1 and IL-23R in the Development of Acute and Chronic Gvhd

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only